Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Mark A McKinlay"'
Autor:
Srinivas K. Chunduru, Mark A. McKinlay, Yigong Shi, David Weng, Martin A. Graham, Matthew D. Alexander, Thomas Haimowitz, Yu-Hua Lee, Pavan K. Tirunahari, Mukta S. Hendi, Yijun Deng, Susan R. Rippin, Matthew G. LaPorte, Gurpreet S. Kapoor, Martin E. Seipel, Guangyao Yu, Stephen M. Condon, Eric M. Neiman, Jennifer M. Burns, Yasuhiro Mitsuuchi, Christopher A. Benetatos
The acquisition of apoptosis resistance is a fundamental event in cancer development. Among the mechanisms used by cancer cells to evade apoptosis is the dysregulation of inhibitor of apoptosis (IAP) proteins. The activity of the IAPs is regulated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749eac6e33c3d6ae4c15d5416ec41d41
https://doi.org/10.1158/1535-7163.c.6536442.v1
https://doi.org/10.1158/1535-7163.c.6536442.v1
Autor:
Srinivas K. Chunduru, Mark A. McKinlay, Yigong Shi, David Weng, Martin A. Graham, Matthew D. Alexander, Thomas Haimowitz, Yu-Hua Lee, Pavan K. Tirunahari, Mukta S. Hendi, Yijun Deng, Susan R. Rippin, Matthew G. LaPorte, Gurpreet S. Kapoor, Martin E. Seipel, Guangyao Yu, Stephen M. Condon, Eric M. Neiman, Jennifer M. Burns, Yasuhiro Mitsuuchi, Christopher A. Benetatos
PDF file - 1384KB, Supplemental Figure 1. Structure of biotinylated birinapant Supplemental Figure 2. Concentration-dependent degradation of GFP-cIAP1/2 by birinapant Supplemental Figure 3. Representative examples of data analysis from 111 cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77cfd31d3e0c71e37181fc6d9362974f
https://doi.org/10.1158/1535-7163.22500405.v1
https://doi.org/10.1158/1535-7163.22500405.v1
Autor:
Srinivas K. Chunduru, Mark A. McKinlay, Yigong Shi, David Weng, Martin A. Graham, Matthew D. Alexander, Thomas Haimowitz, Yu-Hua Lee, Pavan K. Tirunahari, Mukta S. Hendi, Yijun Deng, Susan R. Rippin, Matthew G. LaPorte, Gurpreet S. Kapoor, Martin E. Seipel, Guangyao Yu, Stephen M. Condon, Eric M. Neiman, Jennifer M. Burns, Yasuhiro Mitsuuchi, Christopher A. Benetatos
PDF file - 73KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6017e6fd5bb940ccaf18ea18c0384148
https://doi.org/10.1158/1535-7163.22500408.v1
https://doi.org/10.1158/1535-7163.22500408.v1
Autor:
Srinivas K. Chunduru, Mark A. McKinlay, Yigong Shi, David Weng, Martin A. Graham, Matthew D. Alexander, Thomas Haimowitz, Yu-Hua Lee, Pavan K. Tirunahari, Mukta S. Hendi, Yijun Deng, Susan R. Rippin, Matthew G. LaPorte, Gurpreet S. Kapoor, Martin E. Seipel, Guangyao Yu, Stephen M. Condon, Eric M. Neiman, Jennifer M. Burns, Yasuhiro Mitsuuchi, Christopher A. Benetatos
XLS file - 45KB, Sensitivity of a 111 cell line panel to birinapant as a single agent and in combination with TNF or TRAIL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a5608cfd12aa98c693523b28ad5a19
https://doi.org/10.1158/1535-7163.22500402.v1
https://doi.org/10.1158/1535-7163.22500402.v1
Autor:
Kimberly F. Glassman, Joan S. Brugge, Anthony F. Purchio, Laura T. Kakach, Thomas R. Fuerst, Robert M. Woods, C. Kendall Stover, Srinivas K. Chunduru, Jeffrey R. Hincks, Mark A. McKinlay, Claude H. Nash, Daniel C. Pevear, Thomas P. Monath, Charles M. Rice, Pam Peters
Publikováno v:
Journal of Virology. 97
Autor:
Kimberly F, Glassman, Joan S, Brugge, Anthony F, Purchio, Laura T, Kakach, Thomas R, Fuerst, Robert M, Woods, C Kendall, Stover, Srinivas K, Chunduru, Jeffrey R, Hincks, Mark A, McKinlay, Claude H, Nash, Daniel C, Pevear, Thomas P, Monath, Charles M, Rice, Pam, Peters
Publikováno v:
J Virol
Autor:
Asghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, Steve G. Wassilak, Mark A. Pallansch, Samantha Kluglein, Jessica Quinn, Roland W. Sutter, Xiaochuan Wang, Ozden Sanal, Tatiana Latysheva, Aydan Ikinciogullari, Ewa Bernatowska, Irina A. Tuzankina, Beatriz T. Costa-Carvalho, Jose Luis Franco, Raz Somech, Elif Karakoc-Aydiner, Surjit Singh, Liliana Bezrodnik, Francisco J. Espinosa-Rosales, Anna Shcherbina, Yu-Lung Lau, Shigeaki Nonoyama, Fred Modell, Vicki Modell, The JMF Centers Network Investigators and Study Collaborators, Mohamed-Ridha Barbouche, Mark A. McKinlay
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) have been isolated from primary immunodeficiency (PID) patients exposed to oral poliovirus vaccine (OPV). Patients may excrete poliovirus strains for months or years; the excreted viru
Externí odkaz:
https://doaj.org/article/540d97cccb5b4a768e47d49b624cbe2c
Autor:
Malembe S. Ebama, Rachael M. Porter, Stephen C. Hadler, Eduardo Azziz-Baumgartner, Mark A. McKinlay, Joseph S. Bresee, Kathryn E. Lafond, Susan Y. Chu, Margaret McCarron
Publikováno v:
Vaccine. 39:1892-1896
While seasonal influenza vaccines (SIV) remain the best method to prevent influenza-associated illnesses, implementing SIV programs may benefit countries beyond disease reduction, strengthening health systems and national immunization programs, or co
Autor:
Joseph S. Bresee, Anonh Xeuatvongsa, Fernando Lobos, Beverly Taylor, Pasi Penttinen, Per Etholm, Samir Desai, Josephine P. Golding, Mark A. McKinlay, Lawrence Kerr, John S. Tam, Dominique Richardson, Atika Abelin, Bruce G. Gellin, Joseph R. Scovitch, Alba Maria Ropero Alvarez, Mark Jit, Philippe Boutet, John M Watson, Sophie Mathewson, Marie Mazur, Bruce Ruscio, Samantha Kluglein, Amanda Bolster, Louise Shaxson, Sonia Pagliusi, Niteen Wairagkar, Jennifer E. Seedorff, Hans Christiansen
Publikováno v:
Vaccine. 38:3179-3183
In March 2019, a group of global health leaders with expertise in influenza, vaccinology and pandemic preparedness was convened for a meeting titled "Shaping Meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza
Autor:
Walter A. Orenstein, Lance Rodewald, Mark A. McKinlay, Michael A. Daugherty, Julie Garon, Stephen L. Cochi, Glen Nowak, Alan R. Hinman, Eric E. Mast
Publikováno v:
Vaccine. 37:4928-4936
Background The pace of global progress must increase if the Global Vaccine Action Plan (GVAP) goals are to be achieved by 2020. We administered a two-phase survey to key immunization stakeholders to assess the utility and application of GVAP, includi